PT1301537E - Péptidos e sua utilização em ensaios para doença cardiovascular - Google Patents

Péptidos e sua utilização em ensaios para doença cardiovascular Download PDF

Info

Publication number
PT1301537E
PT1301537E PT01949734T PT01949734T PT1301537E PT 1301537 E PT1301537 E PT 1301537E PT 01949734 T PT01949734 T PT 01949734T PT 01949734 T PT01949734 T PT 01949734T PT 1301537 E PT1301537 E PT 1301537E
Authority
PT
Portugal
Prior art keywords
assays
peptides
cardiovascular disease
cyclised
affinity
Prior art date
Application number
PT01949734T
Other languages
English (en)
Portuguese (pt)
Inventor
Seppo Yla-Herttuala
Outi Narvanen
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Publication of PT1301537E publication Critical patent/PT1301537E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT01949734T 2000-07-18 2001-07-18 Péptidos e sua utilização em ensaios para doença cardiovascular PT1301537E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use

Publications (1)

Publication Number Publication Date
PT1301537E true PT1301537E (pt) 2008-12-04

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01949734T PT1301537E (pt) 2000-07-18 2001-07-18 Péptidos e sua utilização em ensaios para doença cardiovascular

Country Status (12)

Country Link
US (2) US20040091934A1 (enExample)
EP (1) EP1301537B1 (enExample)
JP (1) JP2004504327A (enExample)
AT (1) ATE408626T1 (enExample)
AU (1) AU2001270851A1 (enExample)
CA (1) CA2417789A1 (enExample)
DE (1) DE60135846D1 (enExample)
DK (1) DK1301537T3 (enExample)
ES (1) ES2312455T3 (enExample)
GB (1) GB0017641D0 (enExample)
PT (1) PT1301537E (enExample)
WO (1) WO2002006314A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
EP1438060B1 (en) 2001-09-28 2015-11-11 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
US8926958B2 (en) 2004-04-06 2015-01-06 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
EP2097750A2 (en) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
MX2009006744A (es) * 2006-12-22 2009-06-30 Abbott Lab Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
JP2014516913A (ja) 2010-11-12 2014-07-17 シーダース シナイ メディカル センター 高血圧の治療及び／又は予防のための免疫調節方法及びシステム
RU2013126628A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
JP2019527192A (ja) 2016-05-31 2019-09-26 カーディオバックス リミテッド ライアビリティ カンパニー 全身性エリテマトーデスの診断及び治療方法
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
ATE385575T1 (de) * 1997-06-20 2008-02-15 Leuven Res & Dev Versuchsanordnungen, antikörper und standards für den nachweis von oxidierten und mda-modifizierten lipoproteinen geringer dichte

Also Published As

Publication number Publication date
WO2002006314A3 (en) 2002-04-18
AU2001270851A1 (en) 2002-01-30
JP2004504327A (ja) 2004-02-12
ES2312455T3 (es) 2009-03-01
DK1301537T3 (da) 2008-12-08
EP1301537B1 (en) 2008-09-17
US20040091934A1 (en) 2004-05-13
WO2002006314A2 (en) 2002-01-24
EP1301537A2 (en) 2003-04-16
US20080261234A1 (en) 2008-10-23
GB0017641D0 (en) 2000-09-06
DE60135846D1 (de) 2008-10-30
ATE408626T1 (de) 2008-10-15
CA2417789A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
PT1301537E (pt) Péptidos e sua utilização em ensaios para doença cardiovascular
Cunningham et al. Proline specific peptidases
ATE423127T1 (de) Peptidinhibitoren der ns3-protease des hepatoitis c virus
McIntyre et al. The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide.
AU2002249837A1 (en) Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
ATE500323T1 (de) Subtilisin-variante
MA26221A1 (fr) Nouveaux preconcentres de microemulsion d'analogue de la cyclosporine.
ATE498011T1 (de) Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
WO2002006457A3 (en) Novel lipase genes
EP1053315A4 (en) HUMAN 'HAARLOS' GENE AND PROTEIN AND THEIR USE
WO2002018635A3 (en) Use of nonviable particles comprising an internal control (ic) nucleic acid
KR880701728A (ko) 조직-형 및 우로키나제-형 플라스 미노겐 활성체 억제제의 진단검정 방법 및 억제제의 암호화 유전자
WO2001075157A1 (en) Probe for constructing probe polymer, method of constructing probe polymer and utilization thereof
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
Takahashi et al. Local function of urokinase receptor at the adhesion contact sites of a metastatic tumor cell
Szpacenko et al. A different form of the Ca2+-dependent proteinase activated by micromolar levels of Ca2+
WO2001006019A3 (en) Nucleic acids for detecting parvovirus and methods of using same
WO2002102847A1 (fr) Nouveau ligand et son adn
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
ATE389029T1 (de) Protease assay zur kontrolle medikamentöser therapie
WO2004046371A3 (en) Lipid phosphatase assays in disease and drug discovery
NZ504633A (en) A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
ATE510922T1 (de) Induzierbare promotoren
DE60029108D1 (de) Von zylklischem gmp-abhängige proteinkinase als chemotherapeutisches ziel für gegen protozoen gerichtete agenzien
AU2001295592A1 (en) Method for synthesising peptides, peptide mimetics and proteins